September is likely to see an end to the drought in initial public offerings (IPOs), with at least five issues worth a cumulative Rs 6,250 crore expected to hit the markets. Despite supportive markets and successful new listings, August has seen no IPO.
Many were hoping the strong momentum in the secondary market and the stellar listing of Rossari Biotech in July would prompt more companies to come to the market. Industry players said while companies had regulatory approvals in place, the Covid-19 pandemic led to delays in conducting of roadshows — required to gauge investor appetite — ahead of an